350847-80-2 Usage
General Description
5H-Cyclopenta[c]pyridin-5-one,6,7-dihydro-(9CI) is a chemical compound with the molecular formula C6H7NO. It is a heterocyclic compound containing a cyclopentane ring fused to a pyridine ring, and a ketone functional group. 5H-Cyclopenta[c]pyridin-5-one,6,7-dihydro-(9CI) is also known as dihydropyridinone and is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals and biologically active compounds. It has been studied for its potential anti-inflammatory and anti-cancer properties, and its structure and reactivity make it a valuable intermediate in the development of new drugs and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 350847-80-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,0,8,4 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 350847-80:
(8*3)+(7*5)+(6*0)+(5*8)+(4*4)+(3*7)+(2*8)+(1*0)=152
152 % 10 = 2
So 350847-80-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO/c10-8-2-1-6-5-9-4-3-7(6)8/h3-5H,1-2H2
350847-80-2Relevant articles and documents
Effect of copper(II) triflate on intramolecular Diels-Alder reaction of oxazole-olefins
Ohba, Masashi,Izuta, Rie
, p. 823 - 826 (2001)
Intramolecular Diels - Alder reaction of the oxazole-olefins (8a) and (11a) was effectively promoted by addition of a catalytic amount of copper(II) triflate to afford the cyclopenta[c]pyridines (9a) and (12a), respectively.
DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS
-
Paragraph 0132; 0134; 0283, (2018/03/28)
Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.
